Blood disorders
Lymphoma in Chongqing
重庆 淋巴瘤
6 hospitals in Chongqing
Order: papers led on lymphoma, 2021–2025, then A–Z. Research activity, not a rating of care.
Only hospitals listed for lymphoma: those with enough papers or registered trials on it in the records this site uses. Other hospitals in Chongqing may also treat it. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first.
- 22 papers ledNo open trial led
- 21 papers ledNo open trial led
- 14 papers ledNo open trial led
- 9 papers ledNo open trial led
- 5 papers led
- 5 papers ledNo open trial led
Lymphoma in every city Chongqing on the disease page, with the national map
open trials on lymphoma with a hospital in Chongqing
Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 18 Nov 2026, with a listed hospital in Chongqing as lead sponsor or study site. 1 of them are led by a hospital in Chongqing. Check the registry for the current status. Whether someone can take part is decided by the study team.
Only trials registered on ClinicalTrials.gov are counted. Trials registered only in China’s own registry (ChiCTR) are not.
- RecruitingA Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
- Phase
- Phase 3
- Started
- 2026-03
- Posted
- Registry
- NCT07409428
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 42 listed hospitals as study sitesBeijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Hangzhou, Harbin, Hefei, Jinan, Nanchang, Nanjing, Nanning, Qingdao, Quanzhou, Shanghai, Shenyang, Taiyuan, Tianjin, Wuhan, Xi'an, Xiamen, Xuzhou, Zhengzhou
- RecruitingAssessing Treatment of T-Cell Lymphoma With GW5282 in Combination With Golidocitinib (BEI-DOU3)
- Phase
- Phase 1/Phase 2
- Started
- 2026-04
- Posted
- Registry
- NCT07496229
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 11 listed hospitals as study sitesChengdu, Chongqing, Fuzhou, Nanjing, Nanning, Shanghai, Taiyuan, Wenzhou, Wuhan, Zhengzhou
- RecruitingA Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- Phase
- Phase 3
- Started
- 2025-01
- Posted
- Registry
- NCT06717347
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 20 listed hospitals as study sitesBeijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Hefei, Jinan, Nanchang, Nanning, Nantong, Shanghai, Taiyuan, Tianjin, Wuhan, Xiamen
- RecruitingA Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
- Phase
- Phase 3
- Started
- 2025-03
- Posted
- Registry
- NCT06742996
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 17 listed hospitals as study sitesBeijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Harbin, Linyi, Nanchang, Nanjing, Qingdao, Shanghai, Shenyang, Wenzhou, Wuhan, Xuzhou, Zhengzhou
- RecruitingNewly-diagnosed Pediatric T-cell ALL Protocol
- Phase
- Phase 2/Phase 3
- Started
- 2025-03
- Posted
- Registry
- NCT06855810
Age 1 month to 18 years (registered criteria)
Led by Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC; 13 listed hospitals as study sitesChangsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Hefei, Jinan, Qingdao, Shanghai, Tianjin, Wuhan
- RecruitingA Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
- Phase
- Phase 3
- Started
- 2025-06
- Posted
- Registry
- NCT06943872
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 28 listed hospitals as study sitesBeijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Hohhot, Jinan, Nanchang, Nanjing, Nanning, Qingdao, Shanghai, Shenyang, Shijiazhuang, Tianjin, Wuhan, Wuxi, Xiamen, Yangzhou
- RecruitingA Study to Evaluate the Efficacy and Safety of ICP-248 in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (APEX-06)
- Phase
- Phase 2
- Started
- 2025-08
- Posted
- Registry
- NCT07082686
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 27 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan, Nanchang, Nanjing, Nanning, Qingdao, Shanghai, Tianjin, Urumqi, Wuhan, Xi'an, Zhengzhou
- RecruitingA Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma
- Phase
- Phase 2
- Started
- 2025-11
- Posted
- Registry
- NCT07189065
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 38 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou, Hangzhou, Hefei, Linyi, Luoyang, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Shijiazhuang, Suzhou, Taiyuan, Tianjin, Wuhan, Xiamen, Xuzhou, Zhengzhou
- RecruitingA Global Phase 3 Study of Orelabrutinib+BR Vs.BR in Pts with TN MCL
- Phase
- Phase 3
- Started
- 2024-05
- Posted
- Registry
- NCT06363994
Age 60 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 31 listed hospitals as study sitesBeijing, Bengbu, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan, Luoyang, Nanchang, Nanjing, Ningbo, Shanghai, Shenyang, Shijiazhuang, Taiyuan, Tianjin, Urumqi, Wuhan, Xi'an, Zhengzhou
- RecruitingICP-248 in Combination With Orelabrutinib in Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (APEX-03)
- Phase
- Phase 2/Phase 3
- Started
- 2024-05
- Posted
- Registry
- NCT06378138
Age 18 years to 80 years (registered criteria)
Lead sponsor is not a listed hospital; 43 listed hospitals as study sitesBeijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou, Hangzhou, Hefei, Huai'an, Jinan, Lanzhou, Luoyang, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Shijiazhuang, Taiyuan, Tianjin, Urumqi, Wuhan, Xi'an, Xiamen, Yichang, Zhengzhou, Zunyi
- RecruitingEvaluate the Safety and Efficacy of Tafasitamab and Lenalidomide in Combination With Gemcitabine and Oxaliplatin Versus Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Phase
- Phase 3
- Started
- 2024-05
- Posted
- Registry
- NCT06521255
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 19 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Jinan, Nanchang, Shanghai, Suzhou, Tianjin, Urumqi, Wenzhou, Wuhan, Zhengzhou
- RecruitingA Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19)
- Phase
- Phase 3
- Started
- 2024-05
- Posted
- Registry
- NCT07234162
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 35 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Lanzhou, Linyi, Nanjing, Nanning, Shanghai, Shenyang, Taiyuan, Tianjin, Wenzhou, Wuhan, Xi'an, Xiamen, Zhengzhou
- RecruitingA Study of C-CAR039 (Prizloncabtagene Autoleucel) in Patients With Relapsed/Refractory Large B-Cell Lymphoma
- Phase
- Phase 1/Phase 2
- Started
- 2023-02
- Posted
- Registry
- NCT05800977
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 14 listed hospitals as study sitesBeijing, Chongqing, Guangzhou, Hangzhou, Nanchang, Nanjing, Shanghai, Tianjin, Zhengzhou
- RecruitingA Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
- Phase
- Phase 3
- Started
- 2023-10
- Posted
- Registry
- NCT06084936
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 12 listed hospitals as study sitesBeijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou, Nanning, Shanghai, Shenyang, Wenzhou, Zhengzhou
- RecruitingA Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
- Phase
- Phase 3
- Started
- 2023-12
- Posted
- Registry
- NCT06136559
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 27 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Guiyang, Haikou, Hangzhou, Hefei, Jinan, Nanchang, Nanjing, Nanning, Taiyuan, Tianjin, Urumqi, Wuhan, Xuzhou, Zhengzhou
- RecruitingA Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
- Phase
- Phase 2/Phase 3
- Started
- 2022-01
- Posted
- Registry
- NCT05139017
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 15 listed hospitals as study sitesBeijing, Changchun, Chengdu, Chongqing, Guangzhou, Hangzhou, Luoyang, Nanchang, Shanghai, Wuhan, Zhengzhou
- RecruitingTreatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
- Phase
- Phase 1/Phase 2
- Started
- 2022-05
- Posted
- Registry
- NCT05294731
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 21 listed hospitals as study sitesBeijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan, Nanchang, Nanjing, Qingdao, Shanghai, Suzhou, Taiyuan, Wenzhou, Wuhan, Zhengzhou
- RecruitingStudy of APG2575 Single Agent and Combination Therapy in Patients With Relapsed/Refractory CLL/SLL
- Phase
- Phase 1/Phase 2
- Started
- 2020-08
- Posted
- Registry
- NCT04494503
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 17 listed hospitals as study sitesBeijing, Changchun, Changsha, Chongqing, Guangzhou, Guiyang, Hangzhou, Nanchang, Nanjing, Nanning, Shanghai, Shijiazhuang, Suzhou, Tianjin, Wuhan
- RecruitingPhase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma
- Phase
- Phase 2
- Started
- 2020-10
- Posted
- Registry
- NCT04586478
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 16 listed hospitals as study sitesBeijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Jinan, Shanghai, Tianjin, Wuhan, Zhengzhou
- Not yet recruitingBirelentinib Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (TAI-SHAN19)
- Phase
- Phase 2/Phase 3
- Started
- 2026-09
- Posted
- Registry
- NCT07712588
Age 18 years to 70 years (registered criteria)
Lead sponsor is not a listed hospital; 4 listed hospitals as study sitesChangsha, Chongqing, Harbin, Shanghai
- Not yet recruitingA Phase 3 Study to Compare the Efficacy of ICP-248 in Combination With Orelabrutinib Versus Pirtobrutinib in Participants With Relapsed or Refractory Mantle Cell Lymphoma (r/r MCL).
- Phase
- Phase 3
- Started
- 2026-10
- Posted
- Registry
- NCT07784101
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 24 listed hospitals as study sitesBeijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan, Kunming, Nanjing, Shanghai, Shenyang, Shijiazhuang, Tianjin, Wuhan, Xi'an, Zhengzhou
- Not yet recruitingOrelabrutinib Plus ICP 248 vs Orelabrutinib for Relapsed/Refractory Marginal Zone Lymphoma
- Phase
- Phase 3
- Started
- 2026-10
- Posted
- Registry
- NCT07896590
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 40 listed hospitals as study sitesBeijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Haikou, Hangzhou, Harbin, Hefei, Jinan, Kunming, Lanzhou, Luoyang, Nanchang, Nanjing, Shanghai, Shenyang, Shijiazhuang, Taiyuan, Tianjin, Wuhan, Xi'an, Xiamen, Zhengzhou
- Not yet recruitingAZA Combined with R-GemOx for Elderly DLBCL Patients
- Phase
- Phase 2
- Started
- 2025-02
- Posted
- Registry
- NCT06778902
Age 60 years to 90 years (registered criteria)
Led by Daping Hospital, Army Medical UniversityChongqing
- Not yet recruitingEvaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma
- Phase
- Phase 3
- Started
- 2025-11
- Posted
- Registry
- NCT07187960
Age 18 years to 80 years (registered criteria)
Lead sponsor is not a listed hospital; 19 listed hospitals as study sitesBeijing, Chongqing, Guiyang, Haikou, Lanzhou, Linyi, Nanchang, Nanjing, Shanghai, Shenyang, Taiyuan, Tianjin, Wuhan, Xi'an, Yantai, Zhengzhou
Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.
Disease research in Chongqing
Each number is papers led on that disease, 2021–2025. “Open” counts open trials the hospital leads. Hospitals A–Z; this is not a ranking.
A blank cell means no papers or trials were found in these records. It does not mean the hospital does not treat that disease.
| Cancer | Blood disorders | Other diseases | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital | Nasopharyngeal carcinoma | Oesophageal squamous cell carcinoma | Hepatocellular carcinoma | Stomach cancer | Lung cancer | Pancreatic cancer | Breast cancer | Glioma | Hepatoblastoma | Retinoblastoma | Chordoma | Osteosarcoma | Gastrointestinal stromal tumour | Neuroblastoma | Ewing sarcoma | Multiple myeloma | B-cell acute lymphoblastic leukaemia | Aplastic anaemia | Haemophagocytic lymphohistiocytosis | Lymphoma | Beta thalassaemia | Haemophilia A | Atypical haemolytic uraemic syndrome | Thrombotic thrombocytopenic purpura | Fanconi anaemia | Neuromyelitis optica spectrum disorder | IgG4-related disease | Myasthenia gravis | Moyamoya disease | Wilson disease | Biliary atresia | Coronary heart disease | Congenital heart disease | Scoliosis | Anti-NMDA receptor encephalitis | Takayasu arteritis | Hepatic echinococcosis | Idiopathic pulmonary fibrosis | Lymphangioleiomyomatosis | Amyotrophic lateral sclerosis | Spinal muscular atrophy | Fabry disease | Pompe disease | Duchenne muscular dystrophy | Behçet disease | Alport syndrome | IgA nephropathy | Gaucher disease | Niemann–Pick disease type C | Osteogenesis imperfecta | Primary biliary cholangitis | Primary sclerosing cholangitis | Congenital diaphragmatic hernia | Hirschsprung disease | Inherited epidermolysis bullosa | Hereditary angioedema | Familial adenomatous polyposis | Leber hereditary optic neuropathy | Majeed syndrome | NGLY1 deficiency | ISG15 deficiency | Shortlist |
| Affiliated Hospital of Chongqing Three Gorges Medical College重庆三峡医药高等专科学校附属人民医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Yongchuan Hospital of Chongqing Medical University重庆医科大学附属永川医院 | none | none | none | none | 21 open | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Bishan Hospital, Chongqing Medical University重庆市璧山区人民医院 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Changqing Traditional Chinese Medicine Hospital永川长青中医医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Children's Hospital of Chongqing Medical University重庆医科大学附属儿童医院 | none | none | none | none | none | none | none | 19 | 4 | 1 | none | 6 | none | 49 | 1 | none | 1 | 0 | 7 | 9 | 1 | 0 | none | none | none | none | none | none | none | none | 6 | 14 | 36 | 2 | 10 | 0 | none | 1 | none | 1 | 1 | 0 | 0 | 5 | 1 | none | 3 | none | none | none | 1 | none | 4 | 8 | 1 | none | 1 | 0 | none | none | 1 | |
| Chongqing Aier Eye Hospital重庆爱尔眼科医院 | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Chongqing Bright Eye Hospital重庆普瑞眼科医院 | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Chongqing General Hospital重庆大学附属中心医院(重庆市人民医院) | 3 | none | none | none | none | 12 | 7 | 13 | none | none | none | 3 | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Chongqing Hospital重庆市中医院 | none | none | none | none | none | none | none | none | none | none | none | 2 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | 1 | 0 | none | none | 0 | none | none | none | 0 | none | none | none | none | none | none | |
| Chongqing Liangping District People's Hospital重庆市梁平区人民医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Chongqing Maternal and Child Health Hospital重庆市妇幼保健院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Chongqing University Cancer Hospital重庆大学附属肿瘤医院 | 141 open | 4 | 23 | 15 | 771 open | 7 | 70 | 10 | none | 1 | none | 1 | 0 | 1 | none | 2 | none | none | none | 22 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 2 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | |
| Chongqing University Central Hospital重庆市急救医疗中心 | none | none | none | none | none | none | none | none | none | none | none | 1 | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Chongqing University Fuling Hospital重庆市涪陵中心医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Chongqing University Three Gorges Hospital重庆大学附属三峡医院 | none | 11 open | none | none | 6 | none | none | none | none | none | none | 1 | none | 1 | none | 3 | none | none | none | none | 0 | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | |
| Chongqing Wanzhou District Traditional Chinese Hospital重庆三峡医药高等专科学校附属中医院 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Chongqing Yubei District People's Hospital重庆市渝北区人民医院 | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Daping Hospital, Army Medical University陆军军医大学大坪医院 | 2 | 82 open | none | 93 open | 682 open | none | 161 open | 141 open | none | 1 | none | 5 | 0 | 0 | none | none | none | none | 2 | 51 open | none | none | none | 1 | none | none | none | none | none | none | none | 9 | 2 | none | none | none | none | 1 | none | 3 | none | 1 | none | none | 0 | none | 1 | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | |
| Dapping Hospital | none | none | none | none | 01 open | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Dianjiang People's Hospital重庆市垫江县人民医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| First Affiliated Hospital of Chongqing Medical University重庆医科大学附属第一医院 | 8 | 7 | 641 open | 35 | 111 | 32 | 114 | 16 | none | none | none | 25 | 121 open | 1 | 2 | 4 | none | 1 | none | 21 | 1 | none | none | none | none | 8 | 2 | 10 | none | none | none | 24 | 8 | none | 1 | none | none | 3 | none | 5 | none | none | none | 1 | 28 | none | 1 | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | |
| Fuling Central Hospital重庆市涪陵中心医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Jiangjin Center Hospital重庆大学附属江津医院(重庆市江津区中心医院) | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Second Affiliated Hospital of Chongqing Medical University重庆医科大学附属第二医院 | none | 10 | 108 | 23 | 671 open | 23 | 43 | 18 | none | 5 | none | 7 | 4 | 2 | 1 | none | none | 2 | 2 | none | none | 1 | none | 2 | 1 | none | none | none | none | none | none | 10 | 4 | none | none | 1 | 1 | 1 | none | 1 | none | none | none | none | 1 | none | 1 | none | 1 | none | 0 | none | none | none | none | none | none | none | none | none | none | |
| Shapingba Hospital, Chongqing University重庆市沙坪坝区人民医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Southwest Hospital, Army Medical University陆军军医大学第一附属医院(西南医院) | 3 | 0 | 57 | 242 open | 32 | 14 | 47 | 40 | none | none | none | 7 | 1 | 0 | none | 0 | none | 2 | 2 | 5 | none | none | 0 | none | 1 | none | none | none | 2 | none | none | 7 | 3 | 4 | none | none | none | none | none | 1 | none | none | none | 0 | 1 | none | 1 | none | none | none | 5 | 1 | none | none | 0 | none | none | none | none | none | none | |
| Third Affiliated Hospital of Chongqing Medical University重庆医科大学附属第三医院(方大医院) | none | 3 | none | none | none | none | none | none | none | none | none | 2 | 1 | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 2 | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Third Affiliated Hospital, Army Medical University中国人民解放军陆军特色医学中心 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| University-Town Hospital, Chongqing Medical University重庆医科大学附属大学城医院 | none | none | none | none | none | none | none | none | none | none | none | 2 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Wushan County People's Hospital重庆市巫山县人民医院 | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Xinqiao Hospital, Army Medical University陆军军医大学第二附属医院(新桥医院) | 31 open | none | 23 | 18 | 614 open | 7 | none | 14 | 0 | none | none | 5 | 0 | none | none | 5 | 3 | none | none | 14 | none | 0 | none | 0 | none | none | none | none | none | none | none | 8 | 4 | 2 | none | none | none | none | none | none | none | none | none | none | none | 2 | 4 | none | none | none | none | none | 2 | none | none | none | none | none | none | none | none | |
| Yongchuan Hospital重庆医科大学附属永川医院 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 4 | none | none | 0 | none | none | none | none | none | none | none | none | 0 | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
Column labels are short names. Choose one to open that disease in Chongqing.
- Glioma 19
- Hepatoblastoma 4
- Retinoblastoma 1
- Osteosarcoma 6
- Neuroblastoma 49
- Ewing sarcoma 1
- B-cell acute lymphoblastic leukaemia 1
- Aplastic anaemia 0
- Haemophagocytic lymphohistiocytosis 7
- Lymphoma 9
- Beta thalassaemia 1
- Haemophilia A 0
- Biliary atresia 6
- Coronary heart disease 14
- Congenital heart disease 36
- Scoliosis 2
- Anti-NMDA receptor encephalitis 10
- Takayasu arteritis 0
- Idiopathic pulmonary fibrosis 1
- Amyotrophic lateral sclerosis 1
- Spinal muscular atrophy 1
- Fabry disease 0
- Pompe disease 0
- Duchenne muscular dystrophy 5
- Behçet disease 1
- IgA nephropathy 3
- Primary biliary cholangitis 1
- Congenital diaphragmatic hernia 4
- Hirschsprung disease 8
- Inherited epidermolysis bullosa 1
- Familial adenomatous polyposis 1
- Leber hereditary optic neuropathy 0
- ISG15 deficiency 1
- Nasopharyngeal carcinoma 141 open
- Oesophageal squamous cell carcinoma 4
- Hepatocellular carcinoma 23
- Stomach cancer 15
- Lung cancer 771 open
- Pancreatic cancer 7
- Breast cancer 70
- Glioma 10
- Retinoblastoma 1
- Osteosarcoma 1
- Gastrointestinal stromal tumour 0
- Neuroblastoma 1
- Multiple myeloma 2
- Lymphoma 22
- Amyotrophic lateral sclerosis 2
- Familial adenomatous polyposis 0
- Nasopharyngeal carcinoma 2
- Oesophageal squamous cell carcinoma 82 open
- Stomach cancer 93 open
- Lung cancer 682 open
- Breast cancer 161 open
- Glioma 141 open
- Retinoblastoma 1
- Osteosarcoma 5
- Gastrointestinal stromal tumour 0
- Neuroblastoma 0
- Haemophagocytic lymphohistiocytosis 2
- Lymphoma 51 open
- Thrombotic thrombocytopenic purpura 1
- Coronary heart disease 9
- Congenital heart disease 2
- Idiopathic pulmonary fibrosis 1
- Amyotrophic lateral sclerosis 3
- Fabry disease 1
- Behçet disease 0
- IgA nephropathy 1
- Hirschsprung disease 0
- Nasopharyngeal carcinoma 8
- Oesophageal squamous cell carcinoma 7
- Hepatocellular carcinoma 641 open
- Stomach cancer 35
- Lung cancer 111
- Pancreatic cancer 32
- Breast cancer 114
- Glioma 16
- Osteosarcoma 25
- Gastrointestinal stromal tumour 121 open
- Neuroblastoma 1
- Ewing sarcoma 2
- Multiple myeloma 4
- Aplastic anaemia 1
- Lymphoma 21
- Beta thalassaemia 1
- Neuromyelitis optica spectrum disorder 8
- IgG4-related disease 2
- Myasthenia gravis 10
- Coronary heart disease 24
- Congenital heart disease 8
- Anti-NMDA receptor encephalitis 1
- Idiopathic pulmonary fibrosis 3
- Amyotrophic lateral sclerosis 5
- Duchenne muscular dystrophy 1
- Behçet disease 28
- IgA nephropathy 1
- Inherited epidermolysis bullosa 1
- Oesophageal squamous cell carcinoma 10
- Hepatocellular carcinoma 108
- Stomach cancer 23
- Lung cancer 671 open
- Pancreatic cancer 23
- Breast cancer 43
- Glioma 18
- Retinoblastoma 5
- Osteosarcoma 7
- Gastrointestinal stromal tumour 4
- Neuroblastoma 2
- Ewing sarcoma 1
- Aplastic anaemia 2
- Haemophagocytic lymphohistiocytosis 2
- Haemophilia A 1
- Thrombotic thrombocytopenic purpura 2
- Fanconi anaemia 1
- Coronary heart disease 10
- Congenital heart disease 4
- Takayasu arteritis 1
- Hepatic echinococcosis 1
- Idiopathic pulmonary fibrosis 1
- Amyotrophic lateral sclerosis 1
- Behçet disease 1
- IgA nephropathy 1
- Niemann–Pick disease type C 1
- Primary biliary cholangitis 0
- Nasopharyngeal carcinoma 3
- Oesophageal squamous cell carcinoma 0
- Hepatocellular carcinoma 57
- Stomach cancer 242 open
- Lung cancer 32
- Pancreatic cancer 14
- Breast cancer 47
- Glioma 40
- Osteosarcoma 7
- Gastrointestinal stromal tumour 1
- Neuroblastoma 0
- Multiple myeloma 0
- Aplastic anaemia 2
- Haemophagocytic lymphohistiocytosis 2
- Lymphoma 5
- Atypical haemolytic uraemic syndrome 0
- Fanconi anaemia 1
- Moyamoya disease 2
- Coronary heart disease 7
- Congenital heart disease 3
- Scoliosis 4
- Amyotrophic lateral sclerosis 1
- Duchenne muscular dystrophy 0
- Behçet disease 1
- IgA nephropathy 1
- Primary biliary cholangitis 5
- Primary sclerosing cholangitis 1
- Inherited epidermolysis bullosa 0
- Nasopharyngeal carcinoma 31 open
- Hepatocellular carcinoma 23
- Stomach cancer 18
- Lung cancer 614 open
- Pancreatic cancer 7
- Glioma 14
- Hepatoblastoma 0
- Osteosarcoma 5
- Gastrointestinal stromal tumour 0
- Multiple myeloma 5
- B-cell acute lymphoblastic leukaemia 3
- Lymphoma 14
- Haemophilia A 0
- Thrombotic thrombocytopenic purpura 0
- Coronary heart disease 8
- Congenital heart disease 4
- Scoliosis 2
- Alport syndrome 2
- IgA nephropathy 4
- Congenital diaphragmatic hernia 2
Other cities nearby
Straight-line distance from the city centre; counts are hospitals listed for lymphoma.
Counts are listed hospitals only, not every hospital in each city.
Where these numbers come from
Papers
English-language PubMed papers, 2021–2025, where the first or last author lists the hospital first. Definitions
Trials
ClinicalTrials.gov records with the hospital as lead sponsor or site, as of 8 Nov 2026. Search Chongqing on ClinicalTrials.gov
Locations
Locations are shown at city centres. Check the hospital’s website for its address.